Cellular microRNAs (miRNAs) were identified as a key player in the posttranscriptional
regulation of cellular‐genes regulatory pathways. They also emerged as a significant …

In patients with rheumatic diseases undergoing immunosuppressive treatment, hepatitis B
virus reactivation (HBVr) has been long recognized as a major treatment-related adverse …

Universal hepatitis B virus (HBV) vaccination has been applied for years in most countries,
but HBV infection remains an unresolved public health problem worldwide, with over one …

Background The emerging relationship between microRNAs (miRNA) and viral-control is a
topic of interest in the field of HIV. Host-genome might play an important role in the control of …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer with a dismal
prognosis, especially when diagnosed at advanced stages. Annexin A2 (ANXA2), is found to …

There is currently interest in the risk of infections during treatment with new targeted
synthetic disease-modifying antirheumatic drugs (DMARDs), specifically the Janus kinase …

Background Rheumatoid arthritis (RA) patients seropositive for hepatitis B core antibody
(HBcAb) and negative for hepatitis B surface antigen (HBsAg) are at risk of hepatitis B virus …

Background: TNFα inhibitors are regularly used to treat autoimmune diseases. Tuberculosis
(TB) and viral hepatitis B are considered potential infectious complications, and screening …

Biliary tract cancer, or cholangiocarcinoma, comprises a heterogeneous group of malignant
tumors that can emerge at any part of the biliary tree. This group is the second most common …

The goal of chronic hepatitis B (CHB) therapy is to improve the patient prognosis through the
sustained inhibition of viral replication. However, due to the uncertainty and potentially …